Shares of Theralase Technologies Inc. (CVE:TLT – Get Free Report) were up 25.6% during mid-day trading on Monday . The stock traded as high as C$0.27 and last traded at C$0.25. Approximately 1,195,705 shares changed hands during mid-day trading, an increase of 194% from the average daily volume of 407,275 shares. The stock had previously closed at C$0.20.
Theralase Technologies Stock Up 16.3%
The company has a market capitalization of C$75.50 million, a PE ratio of -15.83 and a beta of -0.35. The company has a current ratio of 1.91, a quick ratio of 3.40 and a debt-to-equity ratio of 14.85. The business has a fifty day moving average of C$0.17 and a 200 day moving average of C$0.19.
About Theralase Technologies
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
Featured Stories
- Five stocks we like better than Theralase Technologies
- A month before the crash
- How a Family Trust May Be Able To Help Preserve Your Wealth
- The $100 Trillion AI Story No One Is Telling You
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- End of America update
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
